Black Rock Inc. Sarepta Therapeutics, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
508Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Capital International Investors Los Angeles, CA9.06MShares$355 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$354 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$160 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$132 Million0.12% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.67MShares$105 Million2.76% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $3.43B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...